Trial Profile

A Phase 1, Multi-Cohort, Single Dose Study to Assess The Relative Bioavailability, Performance, and Safety of Two Novel Formulations of CRN00808

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 10 Jul 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Paltusotine (Primary) ; Paltusotine (Primary) ; Lansoprazole
Indications Acromegaly
Focus Pharmacokinetics
Sponsors Crinetics Pharmaceuticals

Most Recent Events

05 Jul 2021 Planned number of patients changed from 48 to 60.
05 Jul 2021 Status changed from recruiting to completed.
23 Mar 2021 Trial design and dose proportionality for cohorts 1-4 presented at the 103rd Annual Meeting of the Endocrine Society

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com